Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring
Uta Oelschlaegel(University Hospital Carl Gustav Carus), Uwe Platzbecker(National Center for Tumor Diseases), S. Parmentier(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Arjan A. van de Loosdrecht(Dutch Cancer Society), Gerhard Ehninger(University Hospital Carl Gustav Carus), Martin Bornhäuser(Technische Universität Dresden), Theresia M. Westers(Vrije Universiteit Amsterdam), Katja Sockel(Innsbruck Medical University), Christian Thiede(University Hospital Carl Gustav Carus), Brigitte Mohr(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Michael Krämer(University Hospital Carl Gustav Carus)
Cited by 18
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k